Breslin AG

About The Fund

Breslin AG is a private equity fund based in Gossau, Switzerland, that specializes in equity investments across several industries such as BioTech, Energy, CleanTech, Material Science, and Medical Devices & Hospital Services. With a professional focus on Seed, Startup, Early Stage, Expansion, and Later Stage investments, Breslin AG operates with minimum investments of 1,000,000 and up to a maximum of 5,000,000. They manage assets worth 50,000,000 and are known for their strong expertise in the equity sector. The firm prides itself on creating value in Life Sciences through a dedicated investment strategy and advisory services. Breslin AG is an expert in handling transactions and providing customized solutions for small to large-cap global companies and investors in the Life Sciences industry, which includes sub-sectors such as Biotech, Pharma, Medtech, Diagnostics, Bioenergies, Cleantech, and Agro Food. With a history of over 80 successful transactions, predominantly in the Biotech and Pharma markets, they offer meaningful results supported by the skills, experience, and integrated resources of their team. Breslin AG's reputation is underpinned by its committed and experienced professionals who operate independently and confidentially to support and develop the goals of their clients. The firm also operates out of a subsidiary or sister company named Breslin Biotech AG with locations in both Switzerland and Germany, indicating an international presence and ambition within the investment community.